WO2013002750A3 - Détermination de l'origine d'une tumeur - Google Patents

Détermination de l'origine d'une tumeur Download PDF

Info

Publication number
WO2013002750A3
WO2013002750A3 PCT/US2011/031870 US2011031870W WO2013002750A3 WO 2013002750 A3 WO2013002750 A3 WO 2013002750A3 US 2011031870 W US2011031870 W US 2011031870W WO 2013002750 A3 WO2013002750 A3 WO 2013002750A3
Authority
WO
WIPO (PCT)
Prior art keywords
tumor origin
determining tumor
samples
ffpe
classify
Prior art date
Application number
PCT/US2011/031870
Other languages
English (en)
Other versions
WO2013002750A2 (fr
Inventor
Mark Erlander
Xiao-Jun Ma
Original Assignee
Biotheranostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotheranostics, Inc. filed Critical Biotheranostics, Inc.
Priority to PCT/US2011/031870 priority Critical patent/WO2013002750A2/fr
Priority to BR112013026043A priority patent/BR112013026043A2/pt
Priority to CA2864996A priority patent/CA2864996A1/fr
Priority to JP2014518508A priority patent/JP2014518086A/ja
Publication of WO2013002750A2 publication Critical patent/WO2013002750A2/fr
Publication of WO2013002750A3 publication Critical patent/WO2013002750A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des procédés pour l'utilisation de mesures d'expression génique afin d'effectuer une classification ou une identification parmi 54 types de cancer dans des échantillons obtenus à partir d'un sujet dans des conditions cliniques, par exemple dans des cas d'échantillons fixés au formaldéhyde et inclus en paraffine (FFPE).
PCT/US2011/031870 2011-06-29 2011-06-29 Détermination de l'origine d'une tumeur WO2013002750A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PCT/US2011/031870 WO2013002750A2 (fr) 2011-06-29 2011-06-29 Détermination de l'origine d'une tumeur
BR112013026043A BR112013026043A2 (pt) 2011-06-29 2011-06-29 determinação de origem de tumor
CA2864996A CA2864996A1 (fr) 2011-06-29 2011-06-29 Une methode de classification d'un prelevement renfermant des cellules comme un prelevement renfermant des cellules de tumeur ou des tissus
JP2014518508A JP2014518086A (ja) 2011-06-29 2011-06-29 腫瘍起源の決定

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/031870 WO2013002750A2 (fr) 2011-06-29 2011-06-29 Détermination de l'origine d'une tumeur

Publications (2)

Publication Number Publication Date
WO2013002750A2 WO2013002750A2 (fr) 2013-01-03
WO2013002750A3 true WO2013002750A3 (fr) 2013-05-10

Family

ID=47424732

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/031870 WO2013002750A2 (fr) 2011-06-29 2011-06-29 Détermination de l'origine d'une tumeur

Country Status (4)

Country Link
JP (1) JP2014518086A (fr)
BR (1) BR112013026043A2 (fr)
CA (1) CA2864996A1 (fr)
WO (1) WO2013002750A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080104113A (ko) 2005-06-03 2008-12-01 아비아라디엑스, 인코포레이티드 종양 및 조직의 동정방법
CA2905620A1 (fr) 2013-03-15 2014-10-02 Biotheranostics, Inc. Tumeurs neuroendocrines
BR102014003033B8 (pt) * 2014-02-07 2020-12-22 Fleury S/A processo e sistema de classificação de amostras tumorais de origem desconhecida e/ou incerta; processo de controle de qualidade de amostras biológicas tumorais de origem conhecida e processo de controle de qualidade de amostras biológicas de origem desconhecida e/ou incerta

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094035A1 (en) * 2004-06-04 2006-05-04 Arcturus Bioscience, Inc. Identification of tumors
US20070020655A1 (en) * 2005-06-03 2007-01-25 Aviaradx, Inc. Identification of Tumors and Tissues
WO2007137366A1 (fr) * 2006-05-31 2007-12-06 Telethon Institute For Child Health Research Indicateurs de diagnostic et de pronostic du cancer
WO2010108638A1 (fr) * 2009-03-23 2010-09-30 Erasmus University Medical Center Rotterdam Profil d'un gène tumoral

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094035A1 (en) * 2004-06-04 2006-05-04 Arcturus Bioscience, Inc. Identification of tumors
US20070020655A1 (en) * 2005-06-03 2007-01-25 Aviaradx, Inc. Identification of Tumors and Tissues
WO2007137366A1 (fr) * 2006-05-31 2007-12-06 Telethon Institute For Child Health Research Indicateurs de diagnostic et de pronostic du cancer
WO2010108638A1 (fr) * 2009-03-23 2010-09-30 Erasmus University Medical Center Rotterdam Profil d'un gène tumoral

Also Published As

Publication number Publication date
BR112013026043A2 (pt) 2019-02-26
WO2013002750A2 (fr) 2013-01-03
CA2864996A1 (fr) 2013-01-03
JP2014518086A (ja) 2014-07-28

Similar Documents

Publication Publication Date Title
WO2014160645A3 (fr) Tumeurs neuroendocrines
AU2012282905A8 (en) Uses of labeled HSP90 inhibitors
WO2012012725A3 (fr) Méthodes de dépistage de maladies ou d'affections à l'aide de cellules phagocytaires
WO2014160499A3 (fr) Procédés et compositions pour détecter un cancer du pancréas
WO2013006544A8 (fr) Procédé de préparation de polypeptides multimères
WO2012021887A3 (fr) Biomarqueurs pour la détection précoce du cancer du sein
WO2013022786A3 (fr) Biomarqueurs micro-arn
EP2770090A4 (fr) Procédé de préparation d'une banque d'acides nucléiques, ses utilisations, et kits associés
WO2012159025A3 (fr) Analyse de conformation de chromosome
WO2006132971A3 (fr) Identification de tumeurs et de tissus
WO2005118879A3 (fr) Identification de tumeurs
WO2012083969A3 (fr) Microarn pour le diagnostic du cancer du pancréas
EP3640375A3 (fr) Procédés pour identification de récepteur/ligand à rendement élevé
WO2011106709A3 (fr) Biomarqueurs épithéliaux pour pronostiquer un cancer
WO2011112845A3 (fr) Méthodes et compositions associés à un essai de méthylation multiple pour prédire l'évolution de l'état de santé d'un patient
WO2013106844A3 (fr) Procédés et compositions pour le traitement et le diagnostic du cancer du pancréas
EP4202441A3 (fr) Profil d'expression génétique dans les macrophages pour le diagnostic du cancer
WO2013040251A8 (fr) Méthodes et compositions incluant mir-135b, permettant de faire la distinction entre un cancer du pancréas et une maladie pancréatique bénigne
WO2013124738A3 (fr) Méthodes et biomarqueurs permettant de dépister et de pronostiquer le cancer du col utérin
WO2013082249A3 (fr) Compositions et procédés pour l'analyse du cancer de la prostate
WO2012138715A3 (fr) Inhibiteurs à petites molécules de l'épissage de xbp1
WO2012064743A3 (fr) Procédés d'amélioration de la fonction cardiaque
EP3063689A4 (fr) Procédés d'incorporation d'informations de locus chromosomique de transcription pour l'identification de biomarqueurs de risque de récurrence de maladies
WO2013173583A8 (fr) Inhibiteurs de psma
WO2013002750A3 (fr) Détermination de l'origine d'une tumeur

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2014518508

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013026043

Country of ref document: BR

122 Ep: pct application non-entry in european phase

Ref document number: 11868618

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2864996

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 112013026043

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20131009